ARTICLE | Company News
TapImmune, Mayo Clinic deal
April 23, 2012 7:00 AM UTC
TapImmune received exclusive, worldwide rights to major histocompatibility complex class I (MHC) EGFR 2 ( HER2; ErbB2; neu) antigen technology from the clinic. TapImmune says the technology is a go...